Literature DB >> 14534785

Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder.

Kutsal Yorukoglu1, Burcin Tuna, Emel Dikicioglu, Ender Duzcan, Aydin Isisag, Sait Sen, Ugur Mungan, Ziya Kirkali.   

Abstract

OBJECTIVES: This study assessed the diagnostic agreement and intra- and inter-observer reproducibility of the World Health Organization/International Society of Urologic Pathology Consensus Classification of Urothelial Neoplasms (1998 WHO/ISUP classification) and the 1973 WHO classification.
METHODS: A teaching set with 5 slides of each papillary neoplasm of low malignant potential, low-grade papillary carcinoma, high-grade papillary carcinoma, and a guideline, as well as a study set of 30 slides containing ten cases of each category, were sent to participants. Six pathologists expert in urological pathology reviewed the 30 slides of non-invasive papillary urothelial tumors in the study set. Diagnostic accuracy and reproducibility were evaluated using intra- and inter-rater techniques (kappa statistic).
RESULTS: A moderate to substantial intra- and inter-observer reproducibility was achieved for both the 1998 WHO/ISUP and 1973 WHO classification. The results of the two classification systems were not different statistically ( P>0.05). Reproducibility was lower in low-grade tumors for both classifications.
CONCLUSIONS: The new proposed classification system for non-invasive urothelial neoplasms does not increase the reproducibility. There is still a need for uniformity in grading in order to compare the different studies and therapies and to provide more accurate information for management.

Entities:  

Mesh:

Year:  2003        PMID: 14534785     DOI: 10.1007/s00428-003-0905-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  35 in total

1.  World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors.

Authors:  R Oyasu
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

2.  Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.

Authors:  W C Allsbrook; K A Mangold; M H Johnson; R B Lane; C G Lane; J I Epstein
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

3.  Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.

Authors:  J W A Oosterhuis; R F M Schapers; M L G Janssen-Heijnen; R P E Pauwels; D W Newling; F ten Kate
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 4.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

5.  Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.

Authors:  A Pich; L Chiusa; A Formiconi; D Galliano; P Bortolin; R Navone
Journal:  Am J Surg Pathol       Date:  2001-12       Impact factor: 6.394

6.  Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.

Authors:  W A Wells; P A Carney; M S Eliassen; M R Grove; A N Tosteson
Journal:  Am J Surg Pathol       Date:  2000-05       Impact factor: 6.394

7.  Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

Authors:  L Cheng; R M Neumann; A Nehra; B E Spotts; A L Weaver; D G Bostwick
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

8.  Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.

Authors:  L Cheng; R M Neumann; A L Weaver; J C Cheville; B C Leibovich; D M Ramnani; B G Scherer; A Nehra; H Zincke; D G Bostwick
Journal:  Am J Clin Pathol       Date:  2000-02       Impact factor: 2.493

9.  The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.

Authors:  S Holmäng; H Hedelin; C Anderström; S L Johansson
Journal:  J Urol       Date:  1995-06       Impact factor: 7.450

10.  Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility.

Authors:  F B Sørensen; M Sasaki; S Fukuzawa; H Yamabe; S Olsen; O Yoshida
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

View more
  16 in total

1.  Surgical management of bladder transitional cell carcinoma in a vesicular diverticulum: case report.

Authors:  Omer A Raheem; Behdad Besharatian; David P Hickey
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

2.  Reproductibilité des classifications OMS 1973 et OMS 2004 des tumeurs urothéliales papillaires de la vessie.

Authors:  Soumaya Ben Abdelkrim; Soumaya Rammeh; Amel Trabelsi; Lilia Ben Yacoub-Abid; Nabil Ben Sorba; Lilia Jaïdane; Moncef Mokni
Journal:  Can Urol Assoc J       Date:  2011-09-08       Impact factor: 1.862

3.  Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.

Authors:  Burçin Tuna; Kutsal Yörükoglu; Ender Düzcan; Sait Sen; Nalan Nese; Banu Sarsık; Aysegul Akder; Sehnaz Sayhan; Uğur Mungan; Ziya Kirkali
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

4.  Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer.

Authors:  Farha A El-Chennawi; Fatma A Auf; Shereen S Metwally; Youssef M Mosaad; Atallah A Shaaban; Mahmoud Abdo El-Baz; Ziyad E Tawhid; Zakaria F Lotfy
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

Review 5.  Reproducibility and reliability of tumor grading in urological neoplasms.

Authors:  Rainer Engers
Journal:  World J Urol       Date:  2007-09-09       Impact factor: 4.226

6.  Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance.

Authors:  Kien T Mai; Trevor A Flood; Phillip Williams; Zuzana Kos; Eric C Belanger
Journal:  Virchows Arch       Date:  2013-08-04       Impact factor: 4.064

7.  Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.

Authors:  Heejeong Lee; Sun-Young Jun; Youn-Soo Lee; Hee Jin Lee; Weon Sun Lee; Chul Soo Park
Journal:  Virchows Arch       Date:  2013-12-04       Impact factor: 4.064

8.  Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.

Authors:  Amal S El-Shal; Sally M Shalaby; Safwat E Abouhashem; Eman H Abd Elbary; Samir Azazy; Nearmeen M Rashad; Walaa Sarhan
Journal:  Mol Biol Rep       Date:  2021-06-04       Impact factor: 2.316

9.  Diagnostic algorithm for papillary urothelial tumors in the urinary bladder.

Authors:  Jung-Weon Shim; Kang Su Cho; Young-Deuk Choi; Yong-Wook Park; Dong-Wha Lee; Woon-Sup Han; Sang-In Shim; Hyun-Jung Kim; Nam Hoon Cho
Journal:  Virchows Arch       Date:  2008-03-01       Impact factor: 4.064

10.  Role of morphometry and proliferative parameters in grading of urothelial neoplasms.

Authors:  Monika Sangwan; Sunita Singh; Santosh Kumar; Sonia Chabbra; Rajeev Sen; Praveen Rana; Shivani Malik; Sonia Singh; Ramesh Lamba
Journal:  Cent European J Urol       Date:  2015-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.